Erasca, Inc.
ERASNasdaqCIK 1761918HealthcareFiscal year ends Dec 31
Reports and events: 92 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1613:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-423433 |
| 2026-08-2412:15 ET | 8-K | 8.01 Other events | 0001193125-26-361895 |
| 2026-08-1120:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-344611 |
| 2026-08-1120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344584 |
| 2026-08-1021:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-342669 |
| 2026-07-1421:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-303357 |
| 2026-07-1320:19 ET | 8-K | 8.01 Other events | 0001193125-26-302045 |
| 2026-07-0121:41 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-290881 |
| 2026-05-1120:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-216788 |
| 2026-05-1120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216739 |
| 2026-04-2820:40 ET | DEF 14A | Proxy statementPeriod 2026-06-26 | 0001193125-26-187361 |
| 2026-04-2720:17 ET | 8-K | 8.01 Other events | 0001193125-26-182137 |
| 2026-04-2712:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-179214 |
| 2026-04-2113:10 ET | 8-K | 8.01 Other events | 0001193125-26-165297 |
| 2026-03-1220:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-104150 |
| 2026-03-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104105 |
| 2026-01-2921:30 ET | 8-K | 8.01 Other events | 0001193125-26-029467 |
| 2026-01-2222:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-019651 |
| 2026-01-2021:05 ET | 8-K | 2.02 Results of operations | 0001193125-26-016556 |
| 2026-01-1213:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009820 |
| 2025-11-1221:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277625 |
| 2025-11-1221:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277571 |
| 2025-08-1220:27 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-178996 |
| 2025-08-1220:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178950 |
| 2025-06-2621:04 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-090493 |
| 2025-05-1320:24 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070418 |
| 2025-05-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070336 |
| 2025-04-2920:25 ET | DEF 14A | Proxy statementPeriod 2025-06-24 | 0001193125-25-103868 |
| 2025-03-2020:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-042682 |
| 2025-03-2020:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042659 |
| 2025-01-1314:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004613 |
| 2024-11-1221:21 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125481 |
| 2024-11-1221:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125337 |
| 2024-10-2412:10 ET | 8-K | 8.01 Other events | 0000950170-24-116856 |
| 2024-08-1220:12 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095437 |
| 2024-08-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095408 |
| 2024-06-2413:18 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-076476 |
| 2024-06-2413:15 ET | 8-K | 8.01 Other events | 0000950170-24-076474 |
| 2024-05-1710:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-141066 |
| 2024-05-1620:21 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-140591 |
| 2024-05-0820:12 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055668 |
| 2024-05-0820:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055644 |
| 2024-04-2620:06 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001193125-24-117977 |
| 2024-03-2820:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-080630 |
| 2024-03-2720:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-037193 |
| 2024-03-2720:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-037161 |
| 2024-01-3021:41 ET | SC 13D/A | Ownership report, active investor, amended | 0000929638-24-000306 |
| 2024-01-0914:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-003199 |
| 2023-12-1114:19 ET | 8-K | 8.01 Other events | 0000950170-23-069212 |
| 2023-11-2814:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-066250 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.